Gene Query: EIF3L

Dataset Description Geneva Score
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 80.65
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 59.63
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 54.45
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 43.25
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 34.48
Active translatome profiling with RiboLace in MCF7 cells 33.02
RIG-I and MDA5 fRIP during KSHV lytic reactivation 30.41
Role of microRNAs in the interaction between Salmonella and the host cell 28.19
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 27.92
Efficient and quantitative high-throughput tRNA sequencing 26.09
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 25.85
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 25.09
Single-nucleotide-resolution mapping of HBV promoters using CAGE 23.61
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 22.62
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 22.62
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 22.51
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 22.38
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 21.89
3’ Uridylation Expands miRNA Target Repertoire 20.68
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 19.41
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 18.03
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 18.01
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 18.0
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 17.94
Sensing self and nonself circular RNAs 17.92
NRDE2 negatively regulates nuclear exosome functions 16.4
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 15.77
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 15.77
Effects of rFVIIIFc on human macrophages 15.71
Ribosomal footprinting of CN34-Parental and CN34-LM1a 15.55
Macrophage Ad5f35 M2 Challenge 15.33
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 15.04
Ribosomal footprinting of MDA-Parental and MDA-LM2 14.85
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 14.54
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 14.54
Effect of Influenza virus infection on lncRNA expression in A549 cells 14.51
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 14.32
Global analysis of enhancer targets: Mosaic-seq 14.31
Next generation sequencing of small RNAs isolated from exosomes in human semen 14.25
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 14.09
Identification of Atrial Fibrillation associated genes and functional non-coding variants 14.0
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 13.96
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 13.96
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 13.93
An RNA-centric dissection of host complexes controlling flavivirus infection 13.93
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 13.81
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 13.78
Profiling of escape kinetics of viruses subjected to RNAi 13.72
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 13.66
Short and Long RNA sequencing of human mature erythrocytes 13.63
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 13.53
The human blood-nerve barrier transcriptome 13.41
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 13.36
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 13.36
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 13.26
Modeling Familial Cancer with iPSC Approaches 13.25
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 13.02
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 12.9
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 12.87
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 12.56
CROP-Seq in Primary Human T Cells 12.05
RNA sequencing of primary human platelets and in vitro cell lines 11.8
Global response to chemotherapy-induced apoptosis 11.69
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 11.67
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 11.67
Transcriptome of U251 cells overexpression complement component 7 11.66
RNA m5C Methylation in breast cancer using MeRIP-Seq 11.6
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 11.54
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 11.51
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 11.5
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 11.26
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 11.24
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 11.16
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 11.11
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 11.11
RNA-sequencing of formalin fixed human primary melanoma tissue 11.05
Integrating single-cell transcriptomic data across different conditions, technologies, and species 10.95
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 10.91
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 10.43
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 10.31
Genome wide expression change in LCC2 and MCF-7 cells 10.11
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 10.11
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 9.98
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 9.97
Exploring the RNA landscape of endothelial exosomes 9.89
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 9.86
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 9.76
CD95/Fas ligand mRNA is toxic to cells 9.51
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 9.36
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 9.35
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 9.16
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 9.1
Transcriptomic analysis of the HOTAIR-regulated genes 9.0
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 9.0
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 8.97
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 8.94
RNA-Seq with and without RNase treatment in PCa cell lines 8.91
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 8.89
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 8.89
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 8.86
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 8.76
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 8.75
Differential responses of human fetal brain neural stem cells to Zika virus infection 8.71
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 8.63
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 8.54
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 8.48
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 8.36
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 8.33
Transcriptomes of human monocytes after ex vivo exposure to uric acid 8.32
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 8.32
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 8.32
Novel Targeting of Transcription and Metabolism in Glioblastoma 8.27
Identification of renal resident macrophages across species 8.2
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 8.2
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 8.15
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 8.12
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 8.1
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 8.06
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 8.04
RNA-seq melanoma 8.03
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 8.01
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 7.99
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 7.99
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 7.85
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 7.79
MYC dependent mRNA translation shapes gene expression and cell biology 7.75
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 7.69
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 7.62
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 7.62
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 7.6
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 7.55
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 7.54
mRNA expression profile of Lymphocytes 7.53
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 7.49
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 7.45
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 7.44
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 7.43
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 7.42
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 7.42
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 7.41
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 7.34
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 7.29
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 7.28
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 7.2
Transcriptional profiling of microglia; current state of the art and future perspectives 7.16
LINE-2 transposable elements are a source of functional human microRNAs and target sites 7.14
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 7.09
Reassessment of Exosome Composition 7.04
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 7.01
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 7.01
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 6.92
Fibroblasts in cholesteatoma activate osteoclasts. 6.88
Role of XRN2 ribonucleolytic activity in RNA metabolism 6.82
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 6.81
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 6.79
Determination of tRNA aminoacylation levels by high throughput sequencing 6.77
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 6.7
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 6.66
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 6.49
METTL3 and WTAP 6.46
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 6.41
Mitochondrial dsRNA triggers antiviral signalling in humans 6.4
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 6.33
The comparison of high-throughput single-cell RNA-seq methods 6.27
Transcriptome analysis of kidney organoids 6.23
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 6.21
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 6.19
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 6.18
Generation and persistence of human tissue-resident memory T cells in lung transplantation 6.18
Differential Protein Occupancy Profiling of the mRNA Transcriptome 6.13
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 6.12
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 6.09
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 6.03
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 5.95
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 5.91
U1 snRNP telescripting regulates size-function stratified human genome 5.91
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 5.89
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 5.87
An optimization system for isolating and sequencing of single human colon cancer cells 5.85
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 5.77
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 5.73
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 5.68
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 5.65
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 5.64
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 5.62
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 5.6
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 5.59
Argonaute proteins couple chromatin silencing to alternative splicing 5.59
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 5.58
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 5.57
RNASeq of mouse, human, and non-human primate primary dermal fibroblasts to poly(I:C) transfection 5.56
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 5.5
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 5.5
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 5.45
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 5.44
RNA-sequencing in irradiated and normal A549 cells. 5.42
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 5.41
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 5.41
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 5.4
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 5.4
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 5.4
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 5.38
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 5.32
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 5.32
Trans-differentiation of human adult peripheral blood T cells into neurons 5.24
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 5.2
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 5.16
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 5.16
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 5.15
Landscape and variation of RNA secondary structure across the human transcriptome 5.07
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 5.03
Targeting EZH2 in MYCN-amplified Neuroblastoma 5.01
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 5.01
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 4.98
Transcriptome analysis of CNS leukemia 4.98
RNA transcriptome analysis during HSV-1 infection 4.95
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 4.92
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 4.91
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 4.91
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 4.86
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 4.86
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 4.85
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 4.84
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 4.8
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 4.78
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 4.77
Splicing and epigenetic factors jointly regulate epidermal differentiation 4.7
NAPRT activation of macrophages 4.7
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 4.64
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 4.61
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 4.61
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 4.51
Human cells contain natural double-stranded RNAs with potential regulatory capacity 4.5
Transcription elongation regulates genome 3D structure 4.45
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 4.44
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 4.43
Identification of transcription start sites for human A549 cell line using ReCappable-seq 4.41
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 4.41
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 4.4
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 4.39
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 4.39
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 4.34
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 4.34
RNA seq comparison between scrambled and shGRP78 cells 4.34
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 4.34
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 4.34
Intrahepatic MAIT cell gene expression revealed by RNA-seq 4.32
IMP3 regulated gene expression in breast cancer cells 4.3
RNA-Seq following PCR-based sorting reveals rare cell transcriptional signatures 4.27
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 4.24
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 4.24
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 4.24
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 4.23
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 4.23
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 4.22
GRO-seq from HCT116, MCF7 and SJSA cell lines treated with DMSO and Nutlin 4.21
Identification of a core p53 transcriptional program with highly fractionated tumor suppressive activity 4.21
Systematic discovery of endogenous human ribonucleoprotein complexes 4.21
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 4.2
Effect of FGF13 depletion on the H460 cell line 4.08
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 4.07
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 4.06
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 4.06
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 4.04
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 4.04
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 4.02
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 4.02
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 4.01
Widespread regulated alternative splicing of single codons accelerates proteome evolution 3.98
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 3.94
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 3.94
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 3.94
In vitro modeling of human germ cell development using pluripotent stem cells 3.93
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 3.92
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 3.89
Global analyses of the effect of different cellular contexts on microRNA targeting 3.89
The transcriptome and chromatin accessbility landscape of mammalian germline 3.89
Generation and functional characterization of MDSC-like cells 3.81
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 3.8
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 3.8
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 3.74
The age and genomic integrity of neurons after cortical stroke in humans 3.67
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 3.66
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 3.66
Changes in human endometrial gland transcriptome over the window of implantation 3.66
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 3.65
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 3.62
The role of the Calcium-Sensing receptor in colorectal cancer 3.61
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 3.57
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 3.53
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 3.5
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 3.48
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 3.48
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 3.46
RNA-seq analysis of differentiating human erythroblasts 3.44
High-throughput sequencing of PROMPT-enriched samples. 3.4
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 3.38
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 3.31
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 3.31
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 3.29
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 3.28
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 3.27
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 3.22
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 3.2
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 3.2
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 3.19
Transcriptome analysis of peripheral blood monocytes 3.18
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 3.14
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 3.09
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 3.09
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 3.09
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 3.08
RNA-Seq in neutrophils from Antiphospholipid Syndrome 3.07
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 3.04
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 3.03
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 3.03
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 3.02
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 3.01
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 2.99
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 2.98
Mitochondrial hypoxic stress induces RNA editing by APOBEC3G in lymphocytes 2.96
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.96
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 2.96
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 2.96
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.96
Gene expression alterations of pancreatic intraepithlial neoplasia 2.92
Determining mRNA half-lives on a transcriptome-wide scale 2.92
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 2.9
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 2.9
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 2.89
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 2.88
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 2.88
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 2.88
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 2.87
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 2.86
Exogenous rescue of KLHL9 in SF210 cell line 2.85
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 2.83
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 2.82
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 2.81
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 2.81
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 2.81
single cell RNA-seq from GM12878 (ENCSR673UIY) 2.81
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 2.78
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 2.76
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 2.75
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 2.74
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 2.71
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 2.69
ADAR1-editing of cellular and measles virus-derived duplex RNA 2.69
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 2.65
RNA-seq of SCLC PDX models treated with EP 2.65
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 2.65
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 2.6
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 2.56
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.44
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 2.43
p63 controls the enhancer landscape during keratinocyte differentiation 2.4
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 2.39
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 2.39
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 2.32
The transcriptome of Kawasaki Disease arteritis 2.27
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 2.26
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 2.23
Human Tfh cell RNA bulk sequencing 2.22
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 2.22
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 2.1
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 2.09
Gene expression profiling of KSHV-infected periodontal ligament cells 2.07
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 2.05
An interaction with Ewing's sarcoma breakpoint protein EWS defines the specific oncogenic mechanism of ETS factors rearranged in prostate cancer 2.04
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.01
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 1.99
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 1.99
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 1.98
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 1.97
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 1.97
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 1.97
A single-cell transcriptome atlas of the human pancreas 1.96
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.93
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 1.89
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.86
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 1.85
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 1.84
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.83
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.83
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 1.82
Dilated cardiomyopathy vs Myocarditis 1.81
Measure transcript integrity using RNA-seq data 1.8
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.72
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 1.71
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 1.7
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 1.6
Age-Related Gene Expression Changes in Prostate Cancer Patients [RNA-Seq] 1.57
Age-Related Gene Expression Changes in Prostate Cancer Patients 1.57
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.57
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 1.55
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 1.54
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 1.53
Total RNA-Seq data from leukemic patients with complex structural variants 1.5
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 1.49
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.48
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 1.47
Gene expression analysis of human adenomas. 1.47
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.45
Role of cervicovaginal microbiota in genital inflammation 1.44
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 1.43
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.42
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 1.41
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.4
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 1.34
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 1.31
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 1.31
Differential gene expression profiles in imatinib-resistant cell lines 1.3
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 1.28
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 1.24
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 1.23
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 1.21
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 1.18
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.18
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 1.16
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 1.15
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 1.14
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 1.13
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 1.13
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.11
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 1.06
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected uterine smooth muscle cells (USMC) 1.04
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 1.0
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.99
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.99
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 0.98
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.98
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.96
Transcriptional effect of ETV1 knockdown in melanoma cells 0.95
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.94
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.89
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.86
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.83
Identification and validation of differentially expressed transcripts by RNA-Sequencing of formalin-fixed, paraffin-embedded (FFPE) lung tissue from patients with Idiopathic Pulmonary Fibrosis 0.8
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.77
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 0.77
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 0.77
Single-cell transcriptomic analysis of tissue resident memory T cells in human lung cancer [ 10x genomics] 0.73
Myc activation coordinates gene transcription and protein translation responses 0.73
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 0.71
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.7
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 0.7
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 0.65
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.61
RNA-seq of primary patient AML samples 0.6
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.58
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 0.56
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.56
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.56
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 0.53
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 0.52
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.49
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.49
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.47
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.47
Gene expression profiling in metabolically heterogeneous human lung tumors 0.45
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 0.44
siRNA-mediated knockdown 0.43
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.41
Metastasis in triple-negative breast cancer 0.41
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 0.41
Finding missing proteins from epigenetically manipulated human cells 0.41
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.41
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 0.4
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 0.4
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.39
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 0.36
High-resolution comparative analysis of great ape genomes 0.34
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.33
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.32
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.29
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 0.28
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.27
Gene expression activation in CLL mediated by MSCs contact 0.25
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 0.25
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.24
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.22
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 0.2
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 0.2
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.19
Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes 0.18
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.15
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.14
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.12
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.11
The role of m6A/m-RNA methylation in stress response regulation 0.09
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.09
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.04
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.04
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.04
Enhancer activation during EGF response 0.02
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.02
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01
Transcriptomic analysis of human macrophages in 3D 0.01
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation